Your browser doesn't support javascript.
loading
Cell type-specific deletion in mice reveals roles for PAS kinase in insulin and glucagon production.
Semplici, Francesca; Mondragon, Angeles; Macintyre, Benedict; Madeyski-Bengston, Katja; Persson-Kry, Anette; Barr, Sara; Ramne, Anna; Marley, Anna; McGinty, James; French, Paul; Soedling, Helen; Yokosuka, Ryohsuke; Gaitan, Julien; Lang, Jochen; Migrenne-Li, Stephanie; Philippe, Erwann; Herrera, Pedro L; Magnan, Christophe; da Silva Xavier, Gabriela; Rutter, Guy A.
Afiliação
  • Semplici F; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital, du Cane Road, London, W12 0NN, UK.
  • Mondragon A; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital, du Cane Road, London, W12 0NN, UK.
  • Macintyre B; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital, du Cane Road, London, W12 0NN, UK.
  • Madeyski-Bengston K; AstraZeneca R&D, DECS, AstraZeneca R&D, Mölndal, Sweden.
  • Persson-Kry A; AstraZeneca R&D, HC3020, AstraZeneca R&D, Mölndal, Sweden.
  • Barr S; AstraZeneca R&D, DECS, AstraZeneca R&D, Mölndal, Sweden.
  • Ramne A; AstraZeneca R&D, HC3020, AstraZeneca R&D, Mölndal, Sweden.
  • Marley A; AstraZeneca R&D, DECS, AstraZeneca R&D, Mölndal, Sweden.
  • McGinty J; AstraZeneca R&D, HC3020, AstraZeneca R&D, Mölndal, Sweden.
  • French P; AstraZeneca R&D, DECS, AstraZeneca R&D, Mölndal, Sweden.
  • Soedling H; AstraZeneca R&D, HC3020, AstraZeneca R&D, Mölndal, Sweden.
  • Yokosuka R; AstraZeneca R&D, Alderley Edge, UK.
  • Gaitan J; Photonics Group, Department of Physics, Imperial College London, London, UK.
  • Lang J; Photonics Group, Department of Physics, Imperial College London, London, UK.
  • Migrenne-Li S; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital, du Cane Road, London, W12 0NN, UK.
  • Philippe E; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital, du Cane Road, London, W12 0NN, UK.
  • Herrera PL; Université de Bordeaux, Institut de Chimie et Biologie des Membranes et des Nano-objets, CNRS UMR 5248, Pessac, France.
  • Magnan C; Université de Bordeaux, Institut de Chimie et Biologie des Membranes et des Nano-objets, CNRS UMR 5248, Pessac, France.
  • da Silva Xavier G; Paris Diderot University, Unit of Functional and Adaptive Biology (BFA), CNRS UMR 8251, Paris, France.
  • Rutter GA; Paris Diderot University, Unit of Functional and Adaptive Biology (BFA), CNRS UMR 8251, Paris, France.
Diabetologia ; 59(9): 1938-47, 2016 09.
Article em En | MEDLINE | ID: mdl-27338626

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases / Células Secretoras de Glucagon / Células Secretoras de Insulina Limite: Animals Idioma: En Revista: Diabetologia Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases / Células Secretoras de Glucagon / Células Secretoras de Insulina Limite: Animals Idioma: En Revista: Diabetologia Ano de publicação: 2016 Tipo de documento: Article